Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

162 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction to: Clinical Investigation on Endogenous Biomarkers to Predict Strong OAT-Mediated Drug-Drug Interactions.
Willemin ME, Van Der Made TK, Pijpers I, Dillen L, Kunze A, Jonkers S, Steemans K, Tuytelaars A, Jacobs F, Monshouwer M, Scotcher D, Rostami-Hodjegan A, Galetin A, Snoeys J. Willemin ME, et al. Among authors: kunze a. Clin Pharmacokinet. 2022 Mar;61(3):463. doi: 10.1007/s40262-022-01109-2. Clin Pharmacokinet. 2022. PMID: 35175504 No abstract available.
Development of an LC-MS method to quantify coproporphyrin I and III as endogenous biomarkers for drug transporter-mediated drug-drug interactions.
Njumbe Ediage E, Dillen L, Vroman A, Diels L, Kunze A, Snoeys J, Verhaeghe T. Njumbe Ediage E, et al. Among authors: kunze a. J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Jan 15;1073:80-89. doi: 10.1016/j.jchromb.2017.12.008. Epub 2017 Dec 6. J Chromatogr B Analyt Technol Biomed Life Sci. 2018. PMID: 29241088
Population pharmacokinetic modeling and simulation to support qualification of pyridoxic acid as endogenous biomarker of OAT1/3 renal transporters.
Ahmad A, Ogungbenro K, Kunze A, Jacobs F, Snoeys J, Rostami-Hodjegan A, Galetin A. Ahmad A, et al. Among authors: kunze a. CPT Pharmacometrics Syst Pharmacol. 2021 May;10(5):467-477. doi: 10.1002/psp4.12610. Epub 2021 May 1. CPT Pharmacometrics Syst Pharmacol. 2021. PMID: 33704919 Free PMC article. Clinical Trial.
Clinical Investigation on Endogenous Biomarkers to Predict Strong OAT-Mediated Drug-Drug Interactions.
Willemin ME, Van Der Made TK, Pijpers I, Dillen L, Kunze A, Jonkers S, Steemans K, Tuytelaars A, Jacobs F, Monshouwer M, Scotcher D, Rostami-Hodjegan A, Galetin A, Snoeys J. Willemin ME, et al. Among authors: kunze a. Clin Pharmacokinet. 2021 Sep;60(9):1187-1199. doi: 10.1007/s40262-021-01004-2. Epub 2021 Apr 10. Clin Pharmacokinet. 2021. PMID: 33840062 Clinical Trial.
Intestinal organoids as an in vitro platform to characterize disposition, metabolism, and safety profile of small molecules.
Kourula S, Derksen M, Jardi F, Jonkers S, van Heerden M, Verboven P, Theuns V, Van Asten S, Huybrechts T, Kunze A, Frazer-Mendelewska E, Lai KW, Overmeer R, Roos JL, Vries RGJ, Boj SF, Monshouwer M, Pourfarzad F, Snoeys J. Kourula S, et al. Among authors: kunze a. Eur J Pharm Sci. 2023 Sep 1;188:106481. doi: 10.1016/j.ejps.2023.106481. Epub 2023 May 25. Eur J Pharm Sci. 2023. PMID: 37244450 Free article.
162 results